These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3938307)

  • 1. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides in the cerebrospinal fluid (CSF) in psychiatric disorders.
    Rafaelsen OJ; Gjerris A
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):533-8. PubMed ID: 3937176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.
    Sørensen PS; Gjerris A; Hammer M
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):50-7. PubMed ID: 3973621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression?
    Gjerris A
    Acta Psychiatr Scand Suppl; 1988; 345():21-4. PubMed ID: 2906516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression.
    Frye MA; Dunn RT; Gary KA; Kimbrell TA; Callahan AM; Luckenbaugh DA; Corá-Locatelli G; Vanderham E; Winokur A; Post RM
    Biol Psychiatry; 1999 Apr; 45(8):1049-52. PubMed ID: 10386189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings.
    Roy A; Wolkowitz OM; Bissette G; Nemeroff CB
    Am J Psychiatry; 1994 Apr; 151(4):600-2. PubMed ID: 7511876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF-adrenaline--low in "somatizing depression".
    Gjerris A; Rafaelsen OJ; Christensen NJ
    Acta Psychiatr Scand; 1987 May; 75(5):516-20. PubMed ID: 3604737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results.
    Brunner J; Keck ME; Landgraf R; Uhr M; Namendorf C; Bronisch T
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):489-94. PubMed ID: 12208567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia.
    Linkowski P; Geenen V; Kerkhofs M; Mendlewicz J; Legros JJ
    Eur Arch Psychiatry Neurol Sci; 1984; 234(3):162-5. PubMed ID: 6489403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of immunoreactive CSF TRH in depressed patients.
    Banki CM; Bissette G; Arato M; Nemeroff CB
    Am J Psychiatry; 1988 Dec; 145(12):1526-31. PubMed ID: 3143269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders.
    Gjerris A; Rafaelsen OJ; Vendsborg P; Fahrenkrug J; Rehfeld JF
    J Affect Disord; 1984 Dec; 7(3-4):325-37. PubMed ID: 6241214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannitol-induced hyperosmolality and cerebrospinal fluid vasopressin in anesthetized cats.
    Rosenberg GA; Robertson GL
    Neurosci Lett; 1987 Mar; 75(1):60-4. PubMed ID: 3106858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage.
    Cameron V; Espiner EA; Nicholls MG; Donald RA; MacFarlane MR
    Endocrinology; 1985 Apr; 116(4):1460-5. PubMed ID: 2982587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression.
    Frye MA; Gary KA; Marangell LB; George MS; Callahan AM; Little JT; Huggins T; Corá-Locatelli G; Osuch EA; Winokur A; Post RM
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):349-53. PubMed ID: 10440011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
    De Bellis MD; Gold PW; Geracioti TD; Listwak SJ; Kling MA
    Am J Psychiatry; 1993 Apr; 150(4):656-7. PubMed ID: 8465888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal pattern of plasma and cerebrospinal-fluid vasopressin levels in hydrocephalic patients: absence of a circadian rhythm and of a correlation between plasma and cerebrospinal-fluid variations.
    Barreca T; Franceschini R; Siani C; Messina V; Francaviglia N; Perria C; Rolandi E
    Horm Res; 1988; 30(1):28-31. PubMed ID: 3220462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of arginine vasopressin elevated in patients with major depression.
    van Londen L; Goekoop JG; van Kempen GM; Frankhuijzen-Sierevogel AC; Wiegant VM; van der Velde EA; De Wied D
    Neuropsychopharmacology; 1997 Oct; 17(4):284-92. PubMed ID: 9326754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans.
    Peskind ER; Veith RC; Dorsa DM; Gumbrecht G; Raskind MA
    Neuroendocrinology; 1989 Sep; 50(3):286-91. PubMed ID: 2552342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin in blood and third ventricle CSF during dehydration, thirst, and hemorrhage.
    Szczepańska-Sadowska E; Gray D; Simon-Oppermann C
    Am J Physiol; 1983 Oct; 245(4):R549-55. PubMed ID: 6624951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.